PO-1464 Impact of COVID-19 on Radiation Oncology, an Austrian Experience

por Mangesius, J., Arnold, C.R., Frei, A., Thomas, S., Ganswindt, U.
Publicado 2021

Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer – a phase I study

por Ganswindt, U, Budach, W, Jendrossek, V, Becker, G, Bamberg, M, Belka, C
Publicado 2006

Real-time intra-fraction motion management in breast cancer radiotherapy: analysis of 2028 treatment sessions

por Reitz, D., Carl, G., Schönecker, S., Pazos, M., Freislederer, P., Niyazi, M., Ganswindt, U., Alongi, F., Reiner, M., Belka, C., Corradini, S.
Publicado 2018

Optical Surface Scanning for Patient Positioning in Radiation Therapy: A Prospective Analysis of 1902 Fractions

por Carl, G, Reitz, D, Schönecker, S, Pazos, M, Freislederer, P, Reiner, M, Alongi, F, Niyazi, M, Ganswindt, U, Belka, C, Corradini, S
Publicado 2018

Vinorelbine in bladder-preserving multimodality treatment for muscle-invasive bladder cancer—a valid option for cisplatin-unfit patients?

por Arnold, C. R., Lindner, A. K., Schachtner, G., Tulchiner, G., Tulchiner, N., Mangesius, J., Maffei, M., Horninger, W., Kouvaiou, O., Lukas, P., Ganswindt, U., Pichler, R., Skvortsov, S.
Publicado 2021